Survey of steroid usage patterns during and after low-risk penetrating keratoplasty

Cornea

Volumn 28, Issue 8, 2009, Pages 865-870

  Price Jr , Francis W ^a   Price, David A ^a   Ngakeng, Vanessa ^a   Price, Marianne O ^b  

^a PRICE VISION GROUP   (United States)

^b Lautert)   (United States)

Author keywords

Allograft rejection; Corneal graft rejection; Corticosteroids; Penetrating keratoplasty; PKP

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; FLUOROMETHOLONE; LOTEPREDNOL ETABONATE; METHYLPREDNISOLONE; PREDNISOLONE ACETATE; RIMEXOLONE; STEROID; TOBRAMYCIN; TRIAMCINOLONE;

APHAKIA; ARTICLE; DRUG SUBSTITUTION; DRUG USE; GRAFT REJECTION; HEALTH SURVEY; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; PSEUDOPHAKIA; SURGEON;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; APHAKIA; CORNEAL DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG PRESCRIPTIONS; DRUG UTILIZATION; GRAFT REJECTION; HEALTH CARE SURVEYS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS; INTRAOPERATIVE PERIOD; KERATOPLASTY, PENETRATING; POSTOPERATIVE PERIOD; PSEUDOPHAKIA; RISK ASSESSMENT;

EID: 69749092276     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318197ef07     Document Type: Article

References (24)

1. Price FW, Price MO. Adult keratoplasty: has the prognosis improved in the last 25 years? Int Ophthalmol. 2008;28:141-146.
2. Price FW Jr., Whitson WE, Marks RG. Graft survival in four common groups of patients undergoing penetrating keratoplasty. Ophthalmology. 1991;98:322-328.
3. Buxton JN, Apisson JG, Hoefle FB. Corticosteroids in 100 keratoplasties. Am J Ophthalmol. 1969;67:46-51.
4. Chong EM, Dana MR. Graft failure IV: immunologic mechanisms of corneal transplant rejection. Int Ophthalmol. 2008;28:209-222.
5. Coster DJ, Williams KA. Immunosuppression for corneal transplantation and treatment of graft rejection. Transplant Proc. 1989;21(1 Pt 3):3125-3126. (Pubitemid 19124686)
6. Ehlers N, Olsen T, Johnsen HE. Corneal graft rejection probably mediated by antibodies. Acta Ophthalmol (Copenh). 1981;59:119-125. (Pubitemid 11191183)
7. Elliott JH. Immune factors in corneal graft rejection. Invest Ophthalmol. 1971;10:216-234.
8. Hill JC, Ivey A. Corticosteroids in corneal graft rejection: double versus single pulse therapy. Cornea. 1994;13:383-388. (Pubitemid 24260309)
9. Khodadoust A. The allograft rejection reaction: the leading cause of late graft failure of clinical corneal grafts. In: Ciba Foundation Symposium (Porter R, Knight J, editors). New York: Associated Scientific Publishers, 1973:151-163.
10. Niederkorn JY. Mechanisms of corneal graft rejection: the sixth annual Thygeson Lecture. Presented at the Ocular Microbiology and Immunology Group meeting, October 21, 2000. Cornea. 2001;20:675-679.
11. Prendergast DG, Easty DL. Immunological aspects of corneal graft rejection. Immunol Lett. 1991;29 (1-2):73-76.
12. Maumenee A. The influence of donor-recipient sensitization on corneal graft. Am J Ophthalmol. 1051;34:142-152.
13. Rinne JR, Stulting RD. Current practices in the prevention and treatment of corneal graft rejection. Cornea. 1992;11:326-328.
14. Koay PY, Lee WH, Figueiredo FC. Opinions on risk factors and management of corneal graft rejection in the United kingdom. Cornea. 2005;24:292-296.
15. Randleman JB, Stulting RD. Prevention and treatment of corneal graft rejection: current practice patterns (2004). Cornea. 2006;25:286-290.
16. Fleming JC, Reid FR, Wood TO. Prevention of immune graft rejection after corneal transplantation. Am J Ophthalmol. 1979;88:97-101. (Pubitemid 9187776)
17. Hoffmann F, Pahlitzsch T. Predisposing factors in corneal graft rejection. Cornea. 1989;8:215-219. (Pubitemid 19198839)
18. Inoue K, Amano S, Oshika T, et al. Risk factors for corneal graft failure and rejection in penetrating keratoplasty. Acta Ophthalmol Scand. 2001;79:251-255. (Pubitemid 32577308)
19. Maguire MG, Stark WJ, Gottsch JD, et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology. 1994;101:1536-1547.
20. Pinna A, Salvo M, Dore S, Carta F. Corneal graft rejection after penetrating keratoplasty for keratoconus in Turner's syndrome. Eur J Ophthalmol. 2005;15:271-273. (Pubitemid 40677004)
21. Thompson RW Jr, Price MO, Bowers PJ, et al. Long-term graft survival after penetrating keratoplasty. Ophthalmology. 2003;110:1396-1402. (Pubitemid 36842478)
22. Price MO, Price FW Jr. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes. Ophthalmology. 2006;113:1785-1790.
23. Price MO, Thompson RW Jr, Price FW Jr. Risk factors for various causes of failure in initial corneal grafts. Arch Ophthalmol. 2003;121:1087-1092.
24. Nguyen NX, Seitz B, Martus P, et al. Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty. Am J Ophthalmol. 2007;144:318-319. (Pubitemid 47094708)